Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1994 1
1996 1
1998 3
2001 1
2004 2
2005 3
2006 3
2007 3
2008 2
2009 9
2010 7
2011 8
2012 6
2013 13
2014 10
2015 5
2016 10
2017 11
2018 10
2019 5
2020 7
2021 3
2022 11
2023 2
2024 5
2025 3
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

124 results

Results by year

Filters applied: . Clear all
Page 1
Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†.
Piccart M, Hortobagyi GN, Campone M, Pritchard KI, Lebrun F, Ito Y, Noguchi S, Perez A, Rugo HS, Deleu I, Burris HA 3rd, Provencher L, Neven P, Gnant M, Shtivelband M, Wu C, Fan J, Feng W, Taran T, Baselga J. Piccart M, et al. Among authors: provencher l. Ann Oncol. 2014 Dec;25(12):2357-2362. doi: 10.1093/annonc/mdu456. Epub 2014 Sep 17. Ann Oncol. 2014. PMID: 25231953 Free PMC article. Clinical Trial.
Cerulean Cataract.
Provencher LM, Critser B, Johnson AT. Provencher LM, et al. JAMA Ophthalmol. 2018 Dec 1;136(12):e183150. doi: 10.1001/jamaophthalmol.2018.3150. Epub 2018 Dec 13. JAMA Ophthalmol. 2018. PMID: 30543353 No abstract available.
Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2- breast cancer and residual disease after neoadjuvant chemotherapy.
Loibl S, Martin M, Bonnefoi H, Untch M, Kim SB, Bear HD, García-Sáenz JA, Melé Olivé M, Mc Carthy N, Gelmon K, Kelly CM, Im SA, Reimer T, Martinez-Janez M, Zhang Z, Toi M, Provencher L, Rugo HS, Gnant M, Makris A, Antón Torres A, Hirmas N, Holtschmidt J, Nekljudova V, Marmé F. Loibl S, et al. Among authors: provencher l. Ann Oncol. 2025 Jul;36(7):832-837. doi: 10.1016/j.annonc.2025.03.010. Epub 2025 Mar 24. Ann Oncol. 2025. PMID: 40139460 Clinical Trial.
January consultation #4.
Provencher LM. Provencher LM. J Cataract Refract Surg. 2022 Jan 1;48(1):127-128. doi: 10.1097/01.j.jcrs.0000812824.32729.cc. J Cataract Refract Surg. 2022. PMID: 34929715 No abstract available.
A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer.
Cescon DW, Hilton J, Morales Murilo S, Layman RM, Pluard T, Yeo B, Park IH, Provencher L, Kim SB, Im YH, Wyce A, Krishnatry AS, Hicks K, Zhang Q, Barbash O, Khaled A, Horner T, Dhar A, Oliveira M, Sparano JA. Cescon DW, et al. Among authors: provencher l. Clin Cancer Res. 2024 Jan 17;30(2):334-343. doi: 10.1158/1078-0432.CCR-23-0133. Clin Cancer Res. 2024. PMID: 37992310 Free PMC article. Clinical Trial.
Unsprung traps keep PARP inhibitors effective.
Brownlee PM, Provencher L, Goodarzi AA. Brownlee PM, et al. Among authors: provencher l. Nat Cell Biol. 2022 Jan;24(1):2-4. doi: 10.1038/s41556-021-00819-2. Nat Cell Biol. 2022. PMID: 35013555 No abstract available.
Glaucoma-associated corneal endothelial cell damage: A review.
Janson BJ, Alward WL, Kwon YH, Bettis DI, Fingert JH, Provencher LM, Goins KM, Wagoner MD, Greiner MA. Janson BJ, et al. Among authors: provencher lm. Surv Ophthalmol. 2018 Jul-Aug;63(4):500-506. doi: 10.1016/j.survophthal.2017.11.002. Epub 2017 Nov 14. Surv Ophthalmol. 2018. PMID: 29146208 Review.
Deadbolt cataract due to misplanted minishunt.
Ten Hulzen RD, Wagner IV, Aref AA, Provencher LM, Razeghinejad R, Danesh-Meyer HV, Goyal S, De Francesco T, Ahmed IIK. Ten Hulzen RD, et al. Among authors: provencher lm. J Cataract Refract Surg. 2022 Jul 1;48(7):863. doi: 10.1097/j.jcrs.0000000000000979. J Cataract Refract Surg. 2022. PMID: 35749070
124 results